Background:The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
仕様
Synonyms:COXPD17,elaC homolog 2 (E. coli),ElaC homolog protein 2,elaC ribonuclease Z 2,elaC,E. coli,homolog of,2,ELAC2,ELC2,FLJ10530,FLJ36693,FLJ42848,Heredity prostate cancer protein 2,HPC2,putative prostate cancer susceptibility protein HPC2/ELAC2,Ribonuclease Z 2,Ribonuclease Z,long form,Ribonuclease Z2,RNase Z 2,RNase Z2,RNase ZL,RNZ2,tRNA 3 endonuclease 2,tRNase Z (long form),tRNase Z 2,tRNase Z2,Zinc phosphodiesterase ELAC protein 2
Host:Rabbit
Reactivity:Human,Mouse,Rat
Applications:WB,IHC,ELISA
Concentration:0.7mg/mL
Immunogen:Recombinant protein of human ELAC2
Purification Method:Affinity purification
Clonality:Polyclonal
Conjugation:Unconjugated
Buffer:PBS with 0.05% sodium azide, 50% glycerol, PH7.3
Dilution:WB 1:200-1:1000, IHC 1:50-1:200
Swissprot:Q9BQ52
Isotype:IgG
Research Areas:Cancer, Epigenetics and Nuclear Signaling